| pubmed-article:18317125 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18317125 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:18317125 | lifeskim:mentions | umls-concept:C0016055 | lld:lifeskim |
| pubmed-article:18317125 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:18317125 | lifeskim:mentions | umls-concept:C0029418 | lld:lifeskim |
| pubmed-article:18317125 | lifeskim:mentions | umls-concept:C0230445 | lld:lifeskim |
| pubmed-article:18317125 | lifeskim:mentions | umls-concept:C0001511 | lld:lifeskim |
| pubmed-article:18317125 | lifeskim:mentions | umls-concept:C0521457 | lld:lifeskim |
| pubmed-article:18317125 | lifeskim:mentions | umls-concept:C0115137 | lld:lifeskim |
| pubmed-article:18317125 | lifeskim:mentions | umls-concept:C0442805 | lld:lifeskim |
| pubmed-article:18317125 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:18317125 | lifeskim:mentions | umls-concept:C1514485 | lld:lifeskim |
| pubmed-article:18317125 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:18317125 | pubmed:dateCreated | 2008-3-4 | lld:pubmed |
| pubmed-article:18317125 | pubmed:abstractText | The use of hydroxyapatite in reconstructive surgery has been hampered by the fact that it is very slowly invaded by host tissues, a process that is critical to graft incorporation. Implant compatibility may be augmented by providing cellular binding sites and by seeding cells before implantation. | lld:pubmed |
| pubmed-article:18317125 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18317125 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18317125 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:18317125 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18317125 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18317125 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18317125 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18317125 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18317125 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18317125 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:18317125 | pubmed:issn | 1529-4242 | lld:pubmed |
| pubmed-article:18317125 | pubmed:author | pubmed-author:UweBB | lld:pubmed |
| pubmed-article:18317125 | pubmed:author | pubmed-author:TóthG YGY | lld:pubmed |
| pubmed-article:18317125 | pubmed:author | pubmed-author:MehraraBabak... | lld:pubmed |
| pubmed-article:18317125 | pubmed:author | pubmed-author:GewalliFredri... | lld:pubmed |
| pubmed-article:18317125 | pubmed:author | pubmed-author:CordieroPeter... | lld:pubmed |
| pubmed-article:18317125 | pubmed:author | pubmed-author:WongAlex KAK | lld:pubmed |
| pubmed-article:18317125 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18317125 | pubmed:volume | 121 | lld:pubmed |
| pubmed-article:18317125 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18317125 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18317125 | pubmed:pagination | 751-62 | lld:pubmed |
| pubmed-article:18317125 | pubmed:dateRevised | 2011-2-16 | lld:pubmed |
| pubmed-article:18317125 | pubmed:meshHeading | pubmed-meshheading:18317125... | lld:pubmed |
| pubmed-article:18317125 | pubmed:meshHeading | pubmed-meshheading:18317125... | lld:pubmed |
| pubmed-article:18317125 | pubmed:meshHeading | pubmed-meshheading:18317125... | lld:pubmed |
| pubmed-article:18317125 | pubmed:meshHeading | pubmed-meshheading:18317125... | lld:pubmed |
| pubmed-article:18317125 | pubmed:meshHeading | pubmed-meshheading:18317125... | lld:pubmed |
| pubmed-article:18317125 | pubmed:meshHeading | pubmed-meshheading:18317125... | lld:pubmed |
| pubmed-article:18317125 | pubmed:meshHeading | pubmed-meshheading:18317125... | lld:pubmed |
| pubmed-article:18317125 | pubmed:meshHeading | pubmed-meshheading:18317125... | lld:pubmed |
| pubmed-article:18317125 | pubmed:meshHeading | pubmed-meshheading:18317125... | lld:pubmed |
| pubmed-article:18317125 | pubmed:meshHeading | pubmed-meshheading:18317125... | lld:pubmed |
| pubmed-article:18317125 | pubmed:meshHeading | pubmed-meshheading:18317125... | lld:pubmed |
| pubmed-article:18317125 | pubmed:meshHeading | pubmed-meshheading:18317125... | lld:pubmed |
| pubmed-article:18317125 | pubmed:meshHeading | pubmed-meshheading:18317125... | lld:pubmed |
| pubmed-article:18317125 | pubmed:meshHeading | pubmed-meshheading:18317125... | lld:pubmed |
| pubmed-article:18317125 | pubmed:meshHeading | pubmed-meshheading:18317125... | lld:pubmed |
| pubmed-article:18317125 | pubmed:meshHeading | pubmed-meshheading:18317125... | lld:pubmed |
| pubmed-article:18317125 | pubmed:meshHeading | pubmed-meshheading:18317125... | lld:pubmed |
| pubmed-article:18317125 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18317125 | pubmed:articleTitle | Treatment of hydroxyapatite scaffolds with fibronectin and fetal calf serum increases osteoblast adhesion and proliferation in vitro. | lld:pubmed |
| pubmed-article:18317125 | pubmed:affiliation | Division of Plastic and Reconstructive Surgery and Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. | lld:pubmed |
| pubmed-article:18317125 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18317125 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
